Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Search for the Tumor-Associated Proteins of Oral Squamous Cell Carcinoma Collected in Taiwan using Proteomics Strategy

(2011) Kuo-An Liao et al.   JOURNAL OF PROTEOME RESEARCH

Metabolic transformation in cancer

(2009) D. A. Tennant et al.   CARCINOGENESIS

Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-κB in human KU812 cells

(2009) Zafar Rasheed et al.   Journal of Inflammation-London

Control of p53 multimerization by Ubc13 is JNK-regulated

(2009) I. Topisirovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prolidase-dependent regulation of collagen biosynthesis

(2008) A. Surazynski et al.   AMINO ACIDS

The RhoGDI-α/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line

(2008) Yun-Jong Park et al.   CELLULAR SIGNALLING

Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats

(2008) Ismail Celik et al.   FOOD AND CHEMICAL TOXICOLOGY

Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor

(2008) Mee Young Hong et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Search for Potential Markers for Prostate Cancer Diagnosis, Prognosis and Treatment in Clinical Tissue Specimens Using Amine-Specific Isobaric Tagging (iTRAQ) with Two-Dimensional Liquid Chromatography and Tandem Mass Spectrometry

(2008) Spiros D. Garbis et al.   JOURNAL OF PROTEOME RESEARCH

Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor- B-dependent mechanism

(2008) M. B. Rettig et al.   MOLECULAR CANCER THERAPEUTICS